Total Payments
$3,695
2024 Payments
$83.82
Companies
11
Transactions
62
Medicare Patients
17,825
Medicare Billing
$2.6M
Payment Breakdown by Category
Travel$2,528 (68.4%)
Food & Beverage$1,166 (31.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $2,528 | 6 | 68.4% |
| Food and Beverage | $1,166 | 56 | 31.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BIOTRONIK INC. | $3,037 | 23 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $293.96 | 19 | $0 (2019) |
| Abbott Laboratories | $93.79 | 6 | $0 (2021) |
| Boston Scientific Corporation | $60.43 | 3 | $0 (2024) |
| Amgen Inc. | $59.27 | 3 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $38.05 | 2 | $0 (2019) |
| CVRx, Inc. | $28.42 | 1 | $0 (2024) |
| Kiniksa Pharmaceuticals International, plc | $26.42 | 1 | $0 (2024) |
| Medtronic Vascular, Inc. | $25.06 | 2 | $0 (2019) |
| Lundbeck LLC | $17.34 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $83.82 | 3 | Boston Scientific Corporation ($28.98) |
| 2021 | $72.49 | 4 | BIOTRONIK INC. ($54.92) |
| 2020 | $70.42 | 4 | BIOTRONIK INC. ($70.42) |
| 2019 | $157.34 | 11 | Janssen Pharmaceuticals, Inc ($80.24) |
| 2018 | $181.69 | 12 | Janssen Pharmaceuticals, Inc ($113.05) |
| 2017 | $3,129 | 28 | BIOTRONIK INC. ($2,862) |
All Payment Transactions
62 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/21/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $26.42 | General |
| Category: Not Applicable | ||||||
| 10/08/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $28.98 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 03/27/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $28.42 | General |
| Category: Heart Failure and Hypertension | ||||||
| 11/17/2021 | BIOTRONIK INC. | Edora (Device), BioMonitor, Solia | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/21/2021 | Abbott Laboratories | Merlin Connectivity and Remote (Device) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Cardiac Rhythm Management | ||||||
| 02/26/2021 | BIOTRONIK INC. | Solia (Device), BioMonitor, Rivacor | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/10/2021 | BIOTRONIK INC. | Edora (Device), BioMonitor, Solia | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/03/2020 | BIOTRONIK INC. | — | Food and Beverage | In-kind items and services | $20.13 | General |
| 06/10/2020 | BIOTRONIK INC. | — | Food and Beverage | In-kind items and services | $17.20 | General |
| 05/06/2020 | BIOTRONIK INC. | — | Food and Beverage | In-kind items and services | $15.27 | General |
| 02/19/2020 | BIOTRONIK INC. | — | Food and Beverage | In-kind items and services | $17.82 | General |
| 11/26/2019 | BIOTRONIK INC. | — | Food and Beverage | In-kind items and services | $12.35 | General |
| 10/11/2019 | Medtronic Vascular, Inc. | Azure (Device) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: Pacemakers | ||||||
| 09/13/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/06/2019 | BIOTRONIK INC. | — | Food and Beverage | In-kind items and services | $14.29 | General |
| 06/19/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/03/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/18/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/10/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/13/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/06/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/06/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/05/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/15/2018 | BIOTRONIK INC. | — | Food and Beverage | In-kind items and services | $11.09 | General |
| 11/07/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 4,849 | 8,261 | $3.1M | $789,528 |
| 2022 | 28 | 4,489 | 7,571 | $2.6M | $654,120 |
| 2021 | 28 | 4,377 | 7,136 | $2.5M | $651,895 |
| 2020 | 29 | 4,110 | 6,115 | $1.6M | $507,625 |
Total Patients
17,825
Total Services
29,083
Medicare Billing
$2.6M
Procedure Codes
115
All Medicare Procedures & Services
115 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 855 | 2,576 | $953,120 | $232,669 | 24.4% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 207 | 209 | $480,700 | $125,173 | 26.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 310 | 315 | $400,050 | $99,473 | 24.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 400 | 416 | $235,040 | $59,344 | 25.2% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 307 | 624 | $205,920 | $53,921 | 26.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 187 | 292 | $150,380 | $38,078 | 25.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 264 | 267 | $145,515 | $36,476 | 25.1% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 186 | 756 | $113,400 | $31,513 | 27.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 136 | 136 | $65,280 | $16,045 | 24.6% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 311 | 317 | $63,400 | $14,528 | 22.9% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 78 | 80 | $42,800 | $10,840 | 25.3% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 78 | 78 | $40,170 | $9,862 | 24.5% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 51 | 51 | $35,190 | $8,700 | 24.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 639 | 769 | $30,760 | $7,959 | 25.9% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 67 | 113 | $26,555 | $6,509 | 24.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 27 | 32 | $24,526 | $6,425 | 26.2% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 30 | 119 | $5,355 | $4,198 | 78.4% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 181 | 245 | $15,925 | $4,107 | 25.8% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 204 | 208 | $15,600 | $3,954 | 25.3% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 61 | 165 | $14,025 | $3,695 | 26.3% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 76 | 203 | $13,195 | $3,264 | 24.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 39 | $10,140 | $2,421 | 23.9% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 51 | 51 | $11,985 | $2,309 | 19.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $9,525 | $2,291 | 24.1% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 12 | 12 | $7,980 | $2,053 | 25.7% |
About Dr. Andrew Gresko, MD
Dr. Andrew Gresko, MD is a Clinical Cardiac Electrophysiology healthcare provider based in Conway, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1245231372.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Gresko, MD has received a total of $3,695 in payments from pharmaceutical and medical device companies, with $83.82 received in 2024. These payments were reported across 62 transactions from 11 companies. The most common payment nature is "Travel and Lodging" ($2,528).
As a Medicare-enrolled provider, Gresko has provided services to 17,825 Medicare beneficiaries, totaling 29,083 services with total Medicare billing of $2.6M. Data is available for 4 years (2020–2023), covering 115 distinct procedure/service records.
Ad
Practice Information
- Specialty Clinical Cardiac Electrophysiology
- Other Specialties Cardiovascular Disease
- Location Conway, SC
- Active Since 08/10/2005
- Last Updated 02/21/2019
- Taxonomy Code 207RC0001X
- Entity Type Individual
- NPI Number 1245231372
Products in Payments
- XARELTO (Drug) $293.96
- ENTRESTO (Drug) $38.05
- Repatha (Biological) $36.83
- Edora (Device) $31.39
- Connectivity and Remote care (Device) $29.85
- WATCHMAN FLX (Device) $28.98
- Barostim Neo System (Device) $28.42
- Arcalyst (Drug) $26.42
- Solia (Device) $23.53
- Corlanor (Drug) $22.44
- ICDs (Device) $17.72
- Merlin Connectivity and Remote (Device) $17.57
- NORTHERA (Drug) $17.34
- EMBLEM S-ICD (Device) $17.02
- Lexiscan (Drug) $14.97
- CRT-Ds (Device) $14.92
- WATCHMAN (Device) $14.43
- Pacemakers (Device) $13.73
- Reveal LINQ (Device) $12.65
- Azure (Device) $12.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.